Skip to content

Medication Management Among Individuals With Neurodevelopmental Disabilities

Medication Management Among Individuals With Neurodevelopmental Disabilities

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03121651
Acronym
M-MIND
Enrollment
6
Registered
2017-04-20
Start date
2016-11-11
Completion date
2018-12-31
Last updated
2019-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Spina Bifida

Keywords

Mobile technology, Reinforcement-learning, Medication management

Brief summary

This is a pilot study to develop a reinforcement learning (RL)-adaptive visual and interactive support application (hereafter RL-adaptive support) to help young adults with spina bifida or cerebral palsy become more independent with medication management. Individuals with disabilities who are empowered to manage several aspects of their lives can ultimately be better integrated into and contribute more to society.

Detailed description

In this study, an application will be iteratively developed and tested using RL-adaptive support for young adults with disabilities, with the goal to promote the transition to independent self-medication administration among young adults with cerebral palsy and spina bifida. Stochastic mathematical models of how individuals with varying levels of executive function and psychomotor skills will respond to the interventions (i.e. the different types and formats of messages) of the RL-adaptive support will be developed. Up to 6 dyads of individuals with disabilities and their caregivers were intended to be recruited to collaborate in defining the features and content of the RL-adaptive support. The investigators recruited 3 dyads. The steps in developing the RL-adaptive support include having the dyads use for approximately 6 weeks each: 1. young adult uses an electronic medication pillbox that sends its pillbox openings within one hour of opening to the research team, 2. young adult uses the electronic medication pillbox + both use a commercially available medication reminder app + caregiver uses a pillbox opening notification app, and 3. young adult uses the electronic medication pillbox + the RL-adaptive support including push notifications in the form of text messages + caregiver uses the pillbox opening notification app The goal was to reduce the number of caregiver prompts necessary for the medication pillbox to be opened. Using these data, the number and type of prompts necessary for the caregiver to open the electronic pillbox can be determined. In case the young adult does not open the electronic pillbox within two hours, the caregiver will be notified so that pills are not missed. In each step, the useful features of the system will be determined via qualitative and quantitative feedback with specific suggestions about how to improve this supportive system.

Interventions

DEVICERL-adaptive application

Up to 6 dyads of individuals with disabilities and their caregivers will be recruited to collaborate in defining the features and content of the RL-adaptive support. The steps in developing the RL-adaptive support include having the dyads use for approximately 6 weeks each: 1. young adult uses an electronic medication pillbox that sends its pillbox openings within one hour of opening to the research team, 2. young adult uses the electronic medication pillbox + both use a commercially available medication reminder app + caregiver uses a pillbox opening notification app, and 3. young adult uses the electronic medication pillbox + the RL-adaptive support including push notifications in the form of text messages + caregiver uses the pillbox opening notification app. The goal is to reduce the number of caregiver prompts necessary for the medication pillbox to be opened.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Intervention model description

Unblinded pilot study with 1 intervention arm

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

For young adult: * Diagnosed with cerebral palsy or spina bifida and previously enrolled in HUM00081812 * Age 18-26 years-old * Having mild-moderate cognition based on consultation with the investigators and the results of the following tests: iBRIEF Metacognition index T-Score, CVLT List A Free Recall T Score, ReyO Organization T-Score, PPVT Scaled Score, Tower Scaled Score, TRAQ question 4: Do participants take medications correctly and on their own? * Having adequate physical dexterity (to be able to open a pill box and use an iPad/tablet) * Taking two or more routine oral medicines in pill formulation * Being able to take capsules or tablets * Still living at home with their parent/legal guardian * Have Wi-Fi/Internet access at home For parent/caregiver: * Being the parent/legal guardian of a person with aforementioned disability * Owning a cell phone * Have Wi-Fi/Internet access at home

Exclusion criteria

• Those who do not fulfill the inclusion criteria will be excluded from the study

Design outcomes

Primary

MeasureTime frameDescription
Prefer to continue to use RL-adaptive support after study is overat least 18 weeks after beginning studyQualitative feedback

Secondary

MeasureTime frameDescription
Usefulness of the aspects of the RL-adaptive supportEnd of each phase, which lasts approximately 6 weeksQualitative feedback
Most and least helpful aspects of RL-adaptive support applicationEnd of each phase, which lasts approximately 6 weeksQualitative feedback
Ease of use of RL-adaptive support applicationEnd of each phase, which lasts approximately 6 weeksQualitative feedback

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026